PMV Pharmaceuticals, Inc.
PMVP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $55 | $57 | $78 |
| - Cash | $36 | $44 | $51 | $41 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | – | $12 | $6 | $38 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$21 | -$21 | -$22 | -$25 |
| % Margin | – | – | – | – |
| Net Income | -$21 | -$21 | -$17 | -$23 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.397 | -0.41 | -0.34 | 0.37 |
| % Growth | 3.1% | -20.6% | -191.9% | – |
| Operating Cash Flow | -$20 | -$18 | -$18 | -$17 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$20 | -$18 | -$18 | -$17 |